INTRODUCTION
Duchenne muscular dystrophy (DMD) is an X-linked inherited disease for which no effective treatment has been developed. Hence, the detection of carriers is important and is a problem which is not completely solved. The most widely used method for carrier detection consists of measuring the serum level of creatine phosphokinase (CPK) activity, which, although higher in most carriers, can detect only 60 to 70% of genetically proven carriers (Dubowitz, 1975; Roses et al., 1976) . This has prompted many workers to search for alternate and more efficient tests. Other enzymatic activities have been examined in carriers and, more recently, structural and biochemical abnormalities have been observed in red blood cells (Roses et al., 1976; Solomons et al., 1977) , but none of these tests has proven to be superior to the CPK assay (Lane et al., 1978; Seay et al., 1978; Smith and Thomson, 1977) .
Abnormalities in the rate of protein synthesis in dystrophic muscles have been reported by several workers (Moncton and Nihei, 1969; Ionasescu etal., 1971 Ionasescu etal., ,1973 Ionasescu, 1975) and Ionasescu and his collaborators state they can use such abnormalities to detect 98% of the carriers (Ionasescu et al., 1976) . Protein synthesis is a complex process which involves in addition to messenger RNA and ribosomes (the polysomes) transfer RNAs and the soluble factors (aminoacyl-t-RNA synthetases, initiation, elongation, and termination factors) [reviewed in Lengyel, 1974] .
The system devised by Ionasescu et al. to detect carriers is complex, requiring the isolation of polysomes THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES and of soluble factors from muscles. In the present study, we have investigated the rate of protein synthesis using only polysomes extracted from fibroblasts of DMD patients and carriers. The soluble factors are supplied by an extract of wheat germ, therefore limiting the contribution of tested cells to polysomes. It will be shown that a significant decrease in the rate of protein synthesis with polysomes from DMD carriers and patients can be detected. These data are discussed in terms of the possibility of developing an easy, sensitive, and reliable assay for the detection of carriers.
MATERIALS AND METHODS

Subjects
Skin biopsies were performed on 7 dystrophic patients, 7 definite carriers and 7 controls (aged between 17 and 35 years). The diagnosis of Duchenne dystrophy in the patients was based on clinical observations, high CPK level, electromyographic studies, and muscle biopsy. Definite carriers were, according to the definition of Dubowitz (1975) , women with a high CPK level and one or more affected children, or with one affected brother and one or more affected children. Controls were healthy adults.
Chemicals
Eagle's Minimum Essential Medium (MEM) was purchased from Gibco (Grand Island Biological Company, New-York); fresh commercial wheat germ was obtained from General Mills, Chicago, Illinois; [ l4 C] leucine (specific activity, 104 Ci/mol) was from Schwarz-Mann, Orangeburg, New-York; Sephadex G-25 was from Pharmacia; Nonidet P-40 was from Particle Data Laboratories, Elmhurst, Illinois; materials and products for in vitro protein synthesis were obtained from Boehringer-Mannheim Corp; ribonuclease-free sucrose was from Schwarz-Mann.
Skin fibroblast cultures.
Skin specimens were cut into fragments and placed in Falcon dishes with Eagle's MEM supplemented with 20% fetal calf serum and antibiotics. The cultures were incubated at 37° C in a humidified atmosphere with 5% C0 2 , and the culture medium was renewed twice weekly. Cells in the log phase of growth were recovered by centrifugation following trypsination with 0.025% trypsin.
Preparation of the S-30 fraction from the wheat germ lysate and isolation of polysomes from the fibroblast cells.
A 30,000 g supernatant (S-30) from wheat germ crude lysate was prepared following the method of Marcu and Dudock (1974) ). Each experimental point corresponds to an average of at least 3 experiments with different fibroblast cultures. Vertical bars indicate the standard deviation. The linear regression was determined by the least squares method. Assays were optimized for pH and concentration of magnesium and potassium ions.
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•buffer A [200 mM Tris-acetate (pH 8.5), 50 mM KC1, 10 mM magnesium acetate, 4 mM /J-mercaptoethanol] containing 1.5% Nonidet P-40, and homogenized. The homogenate was centrifuged for 10 min at 10,000 g and the supernatant was layered over 1.5 M sucrose in buffer A (5 ml of supernatant over 1.5 ml sucrose cushion) and centrifuged at 105,000 g for 90 min in a Beckman type 50 Ti rotor. The pellet which contained the polysomes was resuspended in buffer B [10 mM Tris-acetate (pH 7.6), 20 mM KC1, 1 mM magnesium acetate, 4 mM /?-mercaptoethanol] and stored at -70° C. The concentration of polysomes was estimated from the measurement of the optical density at 260 nm [1 A 260 unit is 80/xg or 16 pmoles (Tashiro and Yphantis, 1965; Schreier and Staehelin, 1973) ].
Protein synthesizing system.
Protein synthesis was carried out in a reaction volume of 50;ul, containing: ATP, 1.33 mM; GTP, 0.25 mM; creatine phosphate, 15 mM; creatine phosphokinase, 40 /ug/ml; HEPES buffer (pH 7.4), 15 mM; dithiothreitol, 2 mM; [ 12 C] aminoacids -leucine, 0.02 mM; [ 14 C] leucine (104 Ci/mol), 0.02 mM; KC1, 80 mM; magnesium acetate, 3 mM; S-30 from wheat germ, 1 A 260 unit; polysomes, from 0.1 to 1.0 A 260 unit.
The reaction was carried out at 30° C for 60 min and was stopped by addition of 5% trichloroacetic acid. Samples were filtered through Whatman GF/A glass filters which were dried, and the radioactivity determined in a Tri-Carb liquid scintillation spectrometer in a toluene-based scintillation fluid. The counting efficiency was 80%. Fig. 1 shows the [ 14 C] leucine incorporation into trichloroacetic acid precipitable material as a function of the amount of polysomes obtained from DMD patients, carriers, and controls. Results are also expressed as the [
RESULTS AND DISCUSSION
14 C] leucine incorporation per A 260 unit of polysome (Table 1 ). It is clear that there are marked differences in the rate of protein synthesis between polysomes isolated from DMD patients, carriers, and normal individuals. Polysomes from DMD patients exhibit a 3-fold decrease in protein synthesis, while polysomes from carriers are 1.5-fold less active than controls.
These results may seem at variance with those of Ionasescu et al., (1971 Ionasescu et al., ( , 1973 who observed an increase in protein synthesis with DMD patients and carriers. However, it should be pointed out that their assay system was different from ours. Their reaction mixture contained polysomes as well as the soluble factors from the tested cells. Contradictory results were also obtained in the case of dystrophic animals. Indeed, increases as well as decreases in the rate of protein synthesis have been reported (see for example Weinstock and Markiewicz, 1973; Batelle and Florini, 1973; Bester and Gevers, 1973; Petryshyn and Nicholls, 1976) . It is not inferred here that defects other than in polysomes are not present in fibroblasts from DMD patients and carriers, but our system of investigation focuses on polysomes.
A relationship between the abnormalities at the level of protein synthesis observed in this study and the primary defect in DMD is not clear. The pathogenesis of the disease is not completely understood although it seems to involve a membrane defect (Rowland, 1976 ). An interesting observation from these studies is that the genetic lesion does not appear to be restricted to muscles but is also expressed in fibroblasts. Because skin biopsies are easily obtained, it is then obvious that fibroblasts would constitute a suitable material for investigations of DMD. The immediate aim of our research is to develop an improved method for the detection of DMD carriers. In this context, our assay system has revealed clear-cut differences between DMD patients, carriers, and controls. The assay is relatively easy to perform and reproducible. Although it appears to be promising, we realize that a larger number of carriers need to be examined before any definite conclusion can be drawn. Controls (7) 3400 ± 300 Carriers (7) 2040 ± 300 Patients (7) 1 0 6 0 1 3 0 0
The stimulation in incorporation over endogenous background was about 10-fold. Data correspond to patients, carriers, and controls aged between 17 and 35 years and we did not observe any age-dependence in this range. Incorporation of [ l4 C] leucine with polysomes from carriers and patients is significantly different from controls at P values < 0.01.
